0001209191-22-038640.txt : 20220622 0001209191-22-038640.hdr.sgml : 20220622 20220622132333 ACCESSION NUMBER: 0001209191-22-038640 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220617 FILED AS OF DATE: 20220622 DATE AS OF CHANGE: 20220622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAMSAY DAVID A CENTRAL INDEX KEY: 0001283292 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32157 FILM NUMBER: 221031278 MAIL ADDRESS: STREET 1: HALOZYME THERAPEUTICS, INC. STREET 2: 11588 SORRENTO VALLEY ROAD, #17 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Savara Inc CENTRAL INDEX KEY: 0001160308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841318182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6836 BEE CAVE ROAD STREET 2: BUILDING 3, SUITE 201 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 51285113796 MAIL ADDRESS: STREET 1: 6836 BEE CAVE ROAD STREET 2: BUILDING 3, SUITE 201 CITY: AUSTIN STATE: TX ZIP: 78746 FORMER COMPANY: FORMER CONFORMED NAME: Mast Therapeutics, Inc. DATE OF NAME CHANGE: 20130312 FORMER COMPANY: FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030613 FORMER COMPANY: FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010928 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-17 0 0001160308 Savara Inc SVRA 0001283292 RAMSAY DAVID A 6836 BEE CAVE ROAD BUILDING III, SUITE 201 AUSTIN TX 78746 1 0 0 0 Common Stock 2022-06-17 4 P 0 39906 1.326 A 1541048 D Common Stock 2022-06-21 4 P 0 21094 1.38 A 1562142 D Common Stock 2022-06-22 4 P 0 39000 1.445 A 1601142 D The price is a weighted average purchase price. The purchase prices ranged from $1.30 to $1.34. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. The price is a weighted average purchase price. The purchase prices ranged from $1.30 to $1.39. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. The price is a weighted average purchase price. The purchase prices ranged from $1.438 to $1.45. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. /s/ David Lowrance as attorney-in-fact for David Ramsay 2022-06-22